Pluristem Reports Preliminary Data from its COVID-19 Compassionate Use Program, Treating Seven Patients with Acute Respiratory Failure
Stock Information for Pluristem Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.